A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy
Clinical trial NCT05174221 · COMPLETED
Trial details
- NCT number
- NCT05174221
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-16
- Primary completion
- 2025-12-15
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.